Percheron Therapeutics Ltd (ASX:PER – Get Free Report) insider Ben Price acquired 5,000,000 shares of the firm’s stock in a transaction dated Monday, March 31st. The stock was bought at an average price of A$0.01 ($0.01) per share, for a total transaction of A$60,000.00 ($36,363.64).
Percheron Therapeutics Price Performance
Percheron Therapeutics Company Profile
Pernod Ricard SA produces and sells wines and spirits worldwide. It offers its products under various brands. The company was founded in 1805 and is headquartered in Paris, France.
Further Reading
- Five stocks we like better than Percheron Therapeutics
- What Investors Need to Know to Beat the Market
- Conagra Stock Could Thrive as Tariffs Hit Other Sectors
- How to Calculate Stock Profit
- Grocery Costs and Tariffs Now Top of Mind in Everyday Conversations, New Survey Finds
- What is a Secondary Public Offering? What Investors Need to Know
- Spotify Stock Eyes Double-Digit Upside—Is Now the Time to Buy?
Receive News & Ratings for Percheron Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Percheron Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
